Review decisions

Showing 40 results of 292 total
Summary Safety Review - Xeljanz/Xeljanz XR (tofacinitib), Olumiant (baricitinib) and Rinvoq (upadacitinib) - Janus Kinase (JAK) Inhibitors - Assessing the Potential Risks of Serious Heart-related Problems, Blood Clots, Cancer and Death
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00287
Issued / Original Publication Date: 2022-09-16
Summary Safety Review - Nexavar (sorafenib) - Assessing the Potential Risk of Thrombotic Microangiopathy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00286
Issued / Original Publication Date: 2022-08-11
Summary Safety Review - Cholinesterase Inhibitors (donepezil-, rivastigmine- and galantamine-containing products) - Assessing the Potential Risk of QT Interval Prolongation and Torsade de Pointes
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00285
Issued / Original Publication Date: 2022-07-19
Summary Safety Review - Valacyclovir-containing Products - Assessing the Potential Risk of Drug Reaction with Eosinophilia and Systemic Symptoms
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00284
Issued / Original Publication Date: 2022-05-24
Summary Safety Review - Breast Implants - Assessing the Potential Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00283
Issued / Original Publication Date: 2022-04-06
Summary Safety Review - Oral, Over-the-counter Diphenhydramine - Containing Products - Assessing the Potential Risk of Serious Side Effects in Children
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00282
Issued / Original Publication Date: 2022-03-01
Summary Safety Review - Methadone - Assessing the Potential Risk of Hypoglycemia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00281
Issued / Original Publication Date: 2022-02-09
Summary Safety Review - Airvo 2 Humidifier - Assessing the Potential Risk of Breathing Problems Associated with Undetected, Accidental Disconnection of Nasal Cannula
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00280
Issued / Original Publication Date: 2022-01-25
Summary Safety Review - Esophageal Stents - Assessing the Potential Risk of Bilateral Vocal Cord Paralysis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00279
Issued / Original Publication Date: 2022-01-13
Summary Safety Review - Xeljanz/Xeljanz XR (tofacitinib) - Assessing the Potential Risks of Serious Heart-related Problems and Cancer
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00278
Issued / Original Publication Date: 2022-01-12

Displaying 31 - 40 of 292 | Page 4 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: